Role of decidual natural killer cells, interleukin-15, and interferon-γ in placental development and preeclampsia.

Am J Physiol Regul Integr Comp Physiol

Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York; and Cell and Developmental Biology, Weill Cornell Medical College, New York, New York

Published: September 2014

Preeclampsia is a hypertensive, proteinuric disease that affects 5-10% of all pregnancies and is a leading cause of maternal and perinatal morbidity/mortality (Soto et al., J Matern Fetal Neonatal Med 25: 498-507, 2011). The primary treatment for preeclampsia still is delivery of the fetus and placenta. The underlying mechanisms remain elusive. One possibility is inadequate uterine angiogenesis/vascularity (decidualization) at the time of implantation (Torry et al., Am J Reprod Immunol 51: 257-268, 2004). Here, we review evidence for dysregulation of decidual natural killer (dNK) cells, which secrete important angiogenic factors during decidualization, as a contributing factor in preeclampsia.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214833PMC
http://dx.doi.org/10.1152/ajpregu.00176.2014DOI Listing

Publication Analysis

Top Keywords

decidual natural
8
natural killer
8
role decidual
4
killer cells
4
cells interleukin-15
4
interleukin-15 interferon-γ
4
interferon-γ placental
4
placental development
4
preeclampsia
4
development preeclampsia
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!